Rodrigues, Tamara Silva 
; Sá, Keyla Santos Guedes de ; Ishimoto, Adriene Yumi; Becerra, Amanda; Oliveira, Samuel; Almeida, Leticia; Gonçalves, Augusto V.; Perucello, Debora B.; Andrade, Warrison A. ; Castro, Ricardo; Veras, Flavio P.; Toller-Kawahisa, Juliana E.; Nascimento, Daniele C.; Lima, Mikhael H. F. de; Silva, Camila M. S.; Caetite, Diego B.; Martins, Ronaldo Bragança ; Castro, Italo A.; Pontelli, Marjorie C.; Barros, Fabio C. de; Amaral, Natália B. do; Giannini, Marcela C.; Bonjorno, Letícia P.; Lopes, Maria Isabel F.; Santana, Rodrigo de Carvalho ; Vilar, Fernando C.; Auxiliadora-Martins, Maria ; Luppino-Assad, Rodrigo; Almeida, Sergio C. L. de; Oliveira, Fabiola R. de; Batah, Sabrina Setembre ; Siyuan, Li; Benatti, Maira N.; Cunha, Thiago Mattar ; Alves Filho, José Carlos Farias ; Cunha, Fernando de Queiroz ; Cunha, Larissa D.; Frantz, Fabiani Gai ; Kohlsdorf, Tiana ; Fabro, Alexandre Todorovic ; Arruda, Eurico ; Oliveira, Renê D. R. de; Louzada Júnior, Paulo ; Zamboni, Dario Simões
Source: Journal of Experimental Medicine. Unidades: FMRP, FCFRP, FFCLRP
Subjects: COVID-19, INFLAMAÇÃO
ABNT
RODRIGUES, Tamara Silva et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. Journal of Experimental Medicine, v. 218, n. 3, 2021Tradução . . Disponível em: https://doi.org/10.1084/jem.20201707. Acesso em: 05 nov. 2024.APA
Rodrigues, T. S., Sá, K. S. G. de, Ishimoto, A. Y., Becerra, A., Oliveira, S., Almeida, L., et al. (2021). Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. Journal of Experimental Medicine, 218( 3). doi:10.1084/jem.20201707NLM
Rodrigues TS, Sá KSG de, Ishimoto AY, Becerra A, Oliveira S, Almeida L, Gonçalves AV, Perucello DB, Andrade WA, Castro R, Veras FP, Toller-Kawahisa JE, Nascimento DC, Lima MHF de, Silva CMS, Caetite DB, Martins RB, Castro IA, Pontelli MC, Barros FC de, Amaral NB do, Giannini MC, Bonjorno LP, Lopes MIF, Santana R de C, Vilar FC, Auxiliadora-Martins M, Luppino-Assad R, Almeida SCL de, Oliveira FR de, Batah SS, Siyuan L, Benatti MN, Cunha TM, Alves Filho JCF, Cunha F de Q, Cunha LD, Frantz FG, Kohlsdorf T, Fabro AT, Arruda E, Oliveira RDR de, Louzada Júnior P, Zamboni DS. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients [Internet]. Journal of Experimental Medicine. 2021 ; 218( 3):[citado 2024 nov. 05 ] Available from: https://doi.org/10.1084/jem.20201707Vancouver
Rodrigues TS, Sá KSG de, Ishimoto AY, Becerra A, Oliveira S, Almeida L, Gonçalves AV, Perucello DB, Andrade WA, Castro R, Veras FP, Toller-Kawahisa JE, Nascimento DC, Lima MHF de, Silva CMS, Caetite DB, Martins RB, Castro IA, Pontelli MC, Barros FC de, Amaral NB do, Giannini MC, Bonjorno LP, Lopes MIF, Santana R de C, Vilar FC, Auxiliadora-Martins M, Luppino-Assad R, Almeida SCL de, Oliveira FR de, Batah SS, Siyuan L, Benatti MN, Cunha TM, Alves Filho JCF, Cunha F de Q, Cunha LD, Frantz FG, Kohlsdorf T, Fabro AT, Arruda E, Oliveira RDR de, Louzada Júnior P, Zamboni DS. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients [Internet]. Journal of Experimental Medicine. 2021 ; 218( 3):[citado 2024 nov. 05 ] Available from: https://doi.org/10.1084/jem.20201707
